SVRA Company Profile and Key Details

SVRA has shown sold momentum, gaining 3.47% over the past week and 65.37% over the past quarter, though year-to-date performance is down -1.0%. Short-term trend indicators are mixed aligned (SMA20 7.59%, SMA50 2.21%, SMA200 48.66%). The stock’s 14-day RSI is 56.9 (neutral), while the ATR of 0.35 points to higher daily volatility. The stock remains hovering near 52-week lows, trading -14.78% below its high and over 215.87% above its low. Average 10-day trading volume of 2.15 million shares is slightly above the 3-month average of 1.46 million, indicating heightened recent market interest.

Savara Inc. has 172.84 million shares outstanding. The public float is 86.68 million shares, elevated short interest at 12.24% of float. This equals 17.63 million shares. The short ratio is 16.62 days. Institutional investors hold 107.01% of the float. Insiders own 2.57%. Yang Rick holds 24.47 million shares, Walker Paul Edward has 24.47 million shares and Behbahani Ali has 24.47 million shares. Over the past six months, insider transactions show net selling. They sold 394.53 thousand shares across 1 transactions.

Savara Inc. last paid a dividend of 0 per share, Dividend and splits history remains an important factor for investors monitoring long-term returns. A discounted cash flow model estimates fair value at around $0.01. This means the shares are trading above this model’s fair value.

Savara Inc. generated EPS of -$0.54 over the past year. Five-year average earnings growth is 24.35%. Wall Street analysts project EPS growth of 25.73% annually over the next five years. The latest quarter delivered EPS of -$0.15. The next quarter is forecast at -$0.12. Next year's EPS is expected at -$3.47. Analyst sentiment is bullish. Analyst rating data shows there are 6 Strong Buy ratings, 4 Buy ratings, 0 Hold ratings, 0 Sell rating and 0 Strong Sell ratings. Price targets range from $11.00 to $5.00. The high target offers 93.32% upside. The low target suggests -12.13% downside. The mean target is $8.70. This offers 52.9% upside. Savara Inc. earnings surprise history is a consistent trend of beating forecasts. The quarter that ended May 13, 2026, missed forecasts by 7.14%. The prior quarter beat by 7.14%. Over the last six quarters, Apple has recorded several small beats. These include 16.67% in August 13, 2025.

Savara Inc. (NASDAQ:SVRA) closed at $5.79 USD, gaining $0.09 (1.67%) from the previous close of $5.69. The stock is currently mid-range between its 52-week high and low $1.98 and $7.00. With a market capitalization of about $1.19 billion, Savara Inc. is classified as a small-cap and shows lower-than-market volatility (beta ~0.27). Key stats such as the average daily volume over the past year has been around 1.45 million shares, in line with its 52-week average. Headquartered in Langhorne, TX, Savara Inc. operates in the Healthcare sector and the Biotechnology industry. Led by CEO Matthew Pauls, the company employs approximately 59 people and listed since April 28, 2017. Savara Inc. is a biopharmaceutical firm in the clinical development phase, specializing in therapies for uncommon respiratory conditions.

Savara Inc. trades at a P/E ratio of -9.92, slightly below the S&P 500 average, with a price-to-sales ratio of 0.0 and a price-to-book ratio of 7.99 trading at moderately above to book value. The P/FCF stands at -10.64, also below market averages.

Our AI price prediction model suggests that Savara Inc. stock has strong potential for upside but may face short-term weakness followed by gains in the medium and long term. 2-Week Outlook: Projected increase of 2.28%, with price expected at $5.82 by July 06, 2026, within a range of $5.66 to $5.99 3-Month Outlook: Projected rise of 74.17%, reaching $9.91 by September 18, 2026, with a range of $9.45 to $10.36. 1-Year Outlook: Projected gain of 359.4%, with price at $26.14 by June 22, 2027, within a range of $28.18 to $29.44.

Savara Inc. (NASDAQ:SVRA) shares are flat -1.0% year-to-date currently trading near 52-week highs band. Short-term momentum has been positive over the last quarter, despite recent volatility. Valuation shows Savara Inc. trading at a premium to the broader market with a P/E of -9.92. Analyst sentiment is bullish, with the majority of ratings in Buy territory and a mean price target of $10.14, suggesting 78.21% upside. Our AI forecast model points to short-term strength (2.28% over two weeks), a medium-term rise (74.17% over three months), and a longer-term gain (359.4% over one year), with expected trading ranges indicating moderate volatility.